Note sull'episodio
In this episode of The CortiCare Podcast, host @GilSolanoREEGT is joined by neurologist and Sativa Science Chief Science Officer Dr. Swanson to explore the emerging role of non-psychoactive cannabinoids—such as CBD (Cannabidiol) and CBG (Cannabigerol)—in supporting individuals with anxiety disorders and other neurological conditions. Dr. Swanson explains the basics of the endocannabinoid system, shares insights from recent clinical trials, and discusses how cannabinoid-based approaches may complement traditional anti-anxiety treatments.
The conversation also touches on broader topics such as the influence of social media on mental health, strategies for safe and informed dosing, and the ongoing need for more education and research in this space. Whether you're a healthcare professional, student, or someone interested in alternative ...
Parole chiave
Keywords: Cannabinoids, Non-psychoactive cannabinoids, CBD, CBG, Anxiety treatment, Neurology, Anti-anxiety medications, Mental health, Cannabinoid therapy, Clinical trials, Anxiety disorders, Neurological conditions, Drug interactions, Dosing guidel